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IMPORTANCE Rapid thrombolysis treatment for acute ischemic stroke reduces disability
among patients who are carefully selected, but service delivery is challenging.
OBJECTIVE To determine whether an enhanced Paramedic Acute Stroke Treatment
Assessment (PASTA) intervention increased hospital thrombolysis rates.
DESIGN, SETTING, AND PARTICIPANTS This multicenter, cluster randomized clinical trial took
place between December 2015 and July 2018 in 3 ambulance services and 15 hospitals.
Clusters were paramedics based within ambulance stations prerandomized to PASTA or
standard care. Patients attended by study paramedics were enrolled after admission if a
hospital specialist confirmed a stroke and paramedic assessment started within 4 hours of
onset. Allocation to PASTA or standard care reflected the attending paramedic’s
randomization status.
INTERVENTIONS The PASTA intervention included additional prehospital information
collection, a structured hospital handover, practical assistance up to 15 minutes after
handover, a predeparture care checklist, and clinician feedback. Standard care reflected
national guidelines.
MAIN OUTCOMES AND MEASURES Primary outcome was the proportion of patients receiving
thrombolysis. Secondary outcomes included time intervals and day 90 health (with poor
status defined as a modified Rankin Score >2, to represent dependency or death).
RESULTS A total of 11 478 patients were screened following ambulance transportation; 1391
were eligible and approached, but 177 did not consent. Of 1214 patients enrolled (mean [SD]
age, 74.7 [13.2] years; 590 women [48.6%]), 500 were assessed by 242 paramedics trained
in the PASTA intervention and 714 were assessed by 355 paramedics continuing with
standard care. The paramedics trained in the PASTA intervention took a mean of 13.4 (95% CI,
9.4-17.4) minutes longer (P < .001) to complete patient care episodes. There was less
thrombolysis among the patients in the PASTA group, but this was not significant (PASTA
group, 197 of 500 patients [39.4%] vs the standard care group, 319 of 714 patients [44.7%];
adjusted odds ratio, 0.81 [95% CI, 0.61-1.08]; P = .15). Time from a paramedic on scene to
thrombolysis was a mean of 8.5 minutes longer in the PASTA group (98.1 [37.6] minutes) vs
the standard care group (89.4 [31.1] minutes; P = .01). Poor health outcomes did not differ
significantly but occurred less often among patients in the PASTA group (313 of 489 patients
[64.0%]) vs the standard care group (461 of 690 patients [66.8%]; adjusted odds ratio, 0.86
[95% CI, 0.60-1.20]; P = .39).
CONCLUSIONS AND RELEVANCE An enhanced paramedic assessment did not facilitate
thrombolysis delivery. The unexpected combination of thrombolysis and health outcomes
suggests possible alternative influences on treatment decisions by the intervention, requiring
further evaluation.
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I ntravenous thrombolysis administered within 4.5 hours ofsymptom onset reduces disability following acute ische-mic stroke, but outcomes are highly time dependent.1 In
the UK, national audit reports continue to show large differ-
ences in performance between services and diurnal fluctua-
tions attributable to variations in local assessment processes
and stroke specialist availability.2-4 Improvements in deliv-
ery have resulted from hospital-based reorganization of
services,4-6 but many sites still report suboptimal rates and slow
treatment times.2,3
The prehospital phase of emergency stroke care has been
targeted with interventions to facilitate thrombolysis treat-
ment, including multiprofessional workforce training,6 rais-
ing the service priority level for suspected stroke,7 hospital
prenotification,8 and personalized feedback to paramedics
about care quality.9 Reports have described short-term
improvements, but studies were setting specific and/or
observational. In other specialties, there is increasing evi-
dence that simple tools can standardize communication of
key information and confirm whether essential tasks have
been undertaken, including structured formats for paramedic
handover to emergency department staff10,11 and multidisci-
plinary care process checklists.12,13 It has previously been
demonstrated that key information for emergency stroke
treatment decisions is often missing from ambulance clini-
cal records.14 Enhanced handover and team checklists
might therefore be valuable during the routine assessment
of thrombolysis eligibility. We examined whether it was
possible to improve thrombolysis delivery in hospital
following introduction of an enhanced Paramedic Acute
Stroke Treatment Assessment (PASTA) intervention without
additional hospital-based reorganization or whole-system
modification.
Methods
Study Design
A pragmatic, multicenter cluster randomized clinical trial de-
sign was chosen to reduce contamination of standard care by
the intervention and avoid any potential delays in care asso-
ciated with individual randomization. Ethical approval was
granted by the National Research Ethics Committee North East–
Newcastle and North Tyneside 1. The detailed study protocol
(Supplement 2) has been published.15
Study Setting
The study was hosted by 3 ambulance services (North East
England, North West England, and Wales) and 15 hospitals
with acute stroke units (the equivalent to 4 comprehensive
and 11 primary centers). Each ambulance service had similar
clinical pathways for standard care (SC) that reflected
national clinical guidelines,16 including identification using
the Face Arm Speech Test,17 exclusion of hypoglycemia, and
urgent transportation with prenotification to the nearest hos-
pital when time since symptom onset was less than 4 hours.
Participating hospital characteristics are shown in eTable 1 in
Supplement 1.
Randomization and Blinding
Clusters were the individual paramedics based within preran-
domized ambulance stations stratified by service, size, and dis-
tance of station from the nearest study hospital. All ambu-
lance stations serving a study hospital were allocated to PASTA
or SC using simple randomization by the trial statistician (S.I.).
Paramedics based at stations randomized to PASTA only be-
came involved after successful completion of study-specific
training (an online video and a knowledge assessment). Para-
medics based at SC stations were simply informed that their
clinical record entries would be supporting a study of prehos-
pital assessment. Patients received PASTA or SC according to
which paramedic attended the incident. Participating hospi-
tals were not randomized and received patients from both the
PASTA and SC groups. Because of the nature of the interven-
tion, blinding was not possible.
Participants
Patients were identified and recruited after completion of the
thrombolysis assessment in participating hospitals. Adult pa-
tients with stroke were eligible for inclusion if a hospital spe-
cialist confirmed a stroke diagnosis and a study paramedic had
attended within 4 hours of symptom onset.
Patients with capacity gave written informed consent. If
capacity was absent, enrollment was sought via a personal or
a professional consultee. If the patient died before consent
could be obtained, the local principal investigator completed
an early mortality declaration form designed specifically for
this study, and their data were included in the analysis. Postal
consent was introduced following a protocol amendment as
an additional method for patients who were discharged early.
Interventions
A summary of the PASTA pathway is shown in Figure 1 and a
detailed description is given in the eMethods in Supple-
ment 1. The content had been developed over 12 months prior
to study launch using previously published reports and inter-
active workshops with personnel from all participating am-
bulance services and hospitals. Key features were additional
prehospital data collection aimed at thrombolysis treatment
Key Points
Question Can hospital stroke thrombolysis treatment rates be
increased by an enhanced paramedic assessment that includes
additional prehospital information collection, a structured hospital
handover, practical assistance after handover, a predeparture care
checklist, and clinician feedback?
Findings In this cluster randomized clinical trial, fewer patients in
the intervention group (39.4%) received thrombolysis vs those in
the standard care group (44.7%), but there were fewer poor
health outcomes (disability or death) after 90 days (intervention
group, 64.0% vs standard care group, 66.8%). The results were
not statistically significant.
Meaning This study found that the enhanced paramedic
assessment should not be used to increase thrombolysis volume
but may influence the quality of treatment decisions.
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criteria (ie, symptom severity, medical history, clarification of
onset time), a corresponding structured hospital handover, as-
sisting with simple care tasks in hospital for up to 15 minutes
including transfer to the scan room, completing a basic throm-
bolysis assessment checklist before departure, and seeking cli-
nician feedback. Trained paramedics were requested to pro-
vide the intervention to patients whom they suspected were
suffering a stroke and were within 4 hours of symptom onset.
Initial paramedic stroke identification processes were un-
changed. A study-specific ambulance data collection form was
completed to record delivery of the different PASTA com-
ponents. Patients attended by paramedics randomized to SC
received routine assessment and treatment according to
national clinical guidelines.16
Outcome Measures
The primary outcome was the proportion of patients receiv-
ing thrombolysis. Secondary outcomes included key time in-
tervals during assessment and thrombolysis treatment, stroke
severity 24 hours after thrombolysis (National Institute of
Health Stroke Scale18 [NIHSS]), complications after throm-
bolysis, delivery of other components of acute care, day 90 de-
pendency (modified Rankin Scale [mRS] score19,20) and day 90
mortality. Complications assessed included Symptomatic In-
tracranial Hemorrhage, which was defined as at least 4 points
of deterioration on the 24-hour NIHSS score with evidence of
any hemorrhage on repeated brain imaging.21 A standard defi-
nition was used for serious adverse events, but reporting was
not required for preplanned hospitalizations and treatments
for preexisting conditions and predefined expected adverse
events. Outcome data were collected by hospital research staff
from routinely available records and 1 study-specific assess-
ment (undertaken by telephone, mail, or face-to-face con-
tact) at day 90 post stroke.
The primary outcome originally registered was the day 90
mRS score. However, as described in the published protocol,
this was formally amended in October 2017 to the proportion
of patients receiving thrombolysis.15
Statistical Analysis
Based on outcomes reported by previous studies and our eli-
gibility criteria, the sample size estimation considered that a
change from 43% to 53% of patients eligible for the study re-
ceiving thrombolysis would be clinically important. At 90%
power, 5% significance, a mean cluster size (patients per para-
medic) of 5, an intracluster correlation coefficient of 0.02, an
imbalance of 2 control patients per intervention patient (re-
flecting delays in PASTA training uptake), and an attrition rate
Figure 1. Paramedic Acute Stroke Treatment Assessment (PASTA) Pathway Diagram
Information: collect at the scene or indicate if not available
Plus dysphasia or visuospatial impairment
Anticoagulants
Surgery or other bleeding recently
Transient ischemic attack or stroke previously
Assistance needed daily
Handover: FASTA PASTA CT format:
• FAST
• Time when last seen well
• Alertness on AVPU scale
• PASTA information indicating any missing details
• Communication: radiographer ready; rapid registration and
CT request; relatives’ location
• Targets reminder: time for scan is <15 min and thrombolysis
is <30 min
At handover, hospital clinician confirms a provisional
diagnosis of stroke <4 h
Prenotification: all patients according to the local process
15 min since handover
Checklist: Hospital team confirms progress with the assessment
process and decision
Feedback: Paramedic seeks feedback about initial stroke
diagnosis and onset time
Assist according to clinical support present
and operational conditions:
• Transfer to hospital trolley
• Insert intravenous cannula, if none already
• Patient weight measurement or estimation
• Repetition or clarification of handover
and ambulance crew prepares for departure
Scan: patient taken to scan by paramedic
and hospital clinician
AVPU indicates alert, verbally
responsive, responsive to pain, or
unresponsive; CT, communication
and targets; FAST, Face Arm Speech
Test.
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of 1%, it was calculated that 1297 patients were required (865
in the control group and 432 in the intervention group). How-
ever, the study protocol allowed for the final recruitment tar-
get to be kept under review and adjusted to reflect any changes
in the underlying assumptions. The final required number of
patients was 1149, based on a cluster size of 3 and a control:
intervention imbalance of 1.6.
Analysis was by treatment allocated (the study group al-
location of the station base for the attending paramedic). Study
paramedics did not change their PASTA or SC allocation if they
changed stations during the trial. Imputation was used for miss-
ing NIHSS and day 90 mRS scores.
The primary analysis used logistic regression allowing for
clustering by paramedic, with adjustment for clinically im-
portant and statistically significant covariates and factors to
estimate an adjusted odds ratio (aOR) for the proportion of all
patients receiving thrombolysis. The adjustment variables were
not prespecified but determined by stepwise backward selec-
tion from a master list of potential covariates. A Cox regres-
sion estimated a hazard ratio for the combined outcome of the
intervention on thrombolysis and time to treatment since the
emergency call. Other time intervals were compared by t tests
after excluding prespecified improbable time intervals. The
NIHSS scores were compared using t tests. Odds ratios were
calculated using logistic regression for all other comparisons.
Additional binary variables were derived from relevant out-
comes to indicate if patients had any complication after throm-
bolysis and received 1 or more acute care interventions, and
ORs were calculated. The mRS was dichotomized into favor-
able outcome (mRS, 0-2) or poor outcome (mRS, 3-6) and an
aOR of a poor outcome calculated, adjusting as above. Statis-
tical significance was defined by P ≤ .05, 2 tailed. Analyses were
carried out using SPSS version 25 (IBM).
A post hoc analysis considered whether routine hospital
specialist availability for thrombolysis decision-making had any
bearing on treatment received in each study group (as per an
odds ratio calculation). Workforce information reported in the
National Sentinel Stroke Audit Programme Acute Organisa-
tional Audit 20162 was used to categorize hospitals as compli-
ant or noncompliant with the current national recommenda-
tion regarding hospital provision of a specialist thrombolysis
service (ie, there should be a minimum of 6 specialists trained
in emergency stroke care providing a continuous rota with-
out input from nonspecialists, so that all treatment decisions
are made by a stroke specialist) (eTable 1 in Supplement 1).16
Results
One hundred twenty-one ambulance stations with 1540 para-
medics were involved in the trial. At 62 PASTA stations, 453
of 817 paramedics (55.4%) completed training. At 59 SC sta-
tions, 700 of 723 paramedics (96.8%) agreed to assist. Be-
tween December 10, 2015, and July 31, 2018, 11 478 patients
with stroke who traveled by ambulance were screened, 1391
fulfilled the eligibility criteria and were approached, and 1214
patients were enrolled. Of these, 500 were assessed by 242
paramedics trained in the PASTA intervention (2.1 patients/
paramedic) and 714 by 355 paramedics continuing with SC (2.0
patients/paramedic). Follow-up is shown in Figure 2. Pri-
mary outcome data were available for all patients.
Demographic and clinical characteristics were similar in
the 2 study groups for all patients (Table 1) and for patients
treated with thrombolysis (eTable 3 in Supplement 1). The mean
(SD) age was 74.7 (13.2) years; 590 of 1214 patients (48.6%) were
women, and the median and mean admission NIHSS scores
were 9.0 and 11.4, respectively.
Following the 999 call, paramedics trained in the PASTA
intervention took a mean of 13.4 (95% CI, 9.4-17.4) minutes lon-
ger (P < .001) to complete (or clear) patient care episodes than
paramedics continuing with SC, mainly because an addi-
tional 8.8 (95% CI, 6.5-11.0) additional minutes (P < .001) were
spent in the hospital. There was no significant difference be-
tween the groups for paramedic time spent on the scene (PASTA
group, 26.0 minutes; SC group, 24.2 minutes; difference, 1.61
[95% CI, −0.2 to 3.4] minutes; P = .08). Other key ambulance
time intervals are shown in eTable 4 in Supplement 1.
Details about thrombolysis treatment are shown in Table 2.
There was no significant difference in the proportion of pa-
tients who received thrombolysis (primary outcome) be-
tween PASTA (197 of 500 patients [39.4%]) and SC (319 of 714
[44.7%]), but the general direction of this finding was the op-
posite of the anticipated outcome of the intervention (ad-
justed odds ratio, 0.81 [95% CI, 0.61-1.08]; P = .15; intraclass
correlation coefficient, 0.00). The pattern among patients with
ischemic stroke was similar.
In patients treated with thrombolysis, paramedic assess-
ment-to-thrombolysis time in the PASTA group was longer by
a mean of 8.5 minutes (95% CI, 2.1-13.9 minutes; P = .01)
compared with the SC group. Smaller differences in door-
to-needle and onset-to-needle times did not reach statistical
significance, presumably reflecting influences external to the
study intervention (ie, public response to symptoms and am-
bulance availability) and reduced statistical power. The Cox re-
gression analysis of time from 999 call to treatment for inter-
vention versus control groups reported an adjusted hazard ratio
of 0.85 (95% CI, 0.71-1.02; coefficient, −0.17; P = .07), indicat-
ing that intervention group thrombolysis was less likely at any
point after the start of the emergency care pathway, although
statistical significance was not reached. After thrombolysis,
there were no significant differences between groups for re-
duction in stroke severity or any treatment complication, but
the number of events was small (Table 2).
No significant differences were observed for other indi-
vidual acute care processes delivered to all patients (eTable 5
in Supplement 1) or in the number of patients in the PASTA
group who received at least 1 acute care component relative
to SC (odds ratio, 1.16 [95% CI, 0.88-1.54]; P = .28). There was
no significant difference between groups for time from stroke
onset to first brain scan.
At day 90, there was no significant difference between
groups for mortality (PASTA, 140 of 499 patients [28.1%] vs SC,
199 of 712 patients [27.9%]; odds ratio, 1.00 [95% CI, 0.78-
1.30]; P = .97). Figure 3 shows the distribution of mRS values
at day 90. Although lacking statistical significance, there were
numerically fewer poor outcomes (mRS score ≥3) at day 90
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among patients in the intervention group (PASTA, 313 of 489
patients [64.0%] vs SC, 461 of 690 patients [66.8%]; aOR, 0.86
[95% CI, 0.60-1.2]; P = .39), which was also seen among those
who received thrombolysis (PASTA, 108 of 193 patients [56.0%]
vs 191 of 312 patients [61.2%]; aOR, 0.78 [95% CI, 0.47-1.30];
P = .34). eFigures 1 and 2 in Supplement 1 show day 90 mRS
distributions for thrombolysis and nonthrombolysis groups.
Serious adverse events were recorded from 81 patients in the
PASTA group (16.2%; 94 total events) and 136 patients in the SC
group (19%; 161 total events). None had a causal link to the
study intervention.
In the post hoc analysis, 8 hospitals were not fully com-
pliant with the national recommendation for local specialist
availability (eTable 1 in Supplement 1). These noncompliant ser-
vices had a statistically significant 9.8% absolute reduction in
the PASTA thrombolysis treatment rate relative to SC (PASTA,
99 of 276 patients [35.9%] vs SC, 105 of 230 patients [45.7%];
unadjusted OR, 0.67 [95% CI, 0.47-0.95]; P = .03), whereas the
7 hospitals that were compliant showed only a 0.4% reduc-
tion (PASTA, 98 of 224 patients [43.8%] vs SC, 214 of 484
patients [44.2%]; unadjusted OR, 0.98 [95% CI, 0.71-1.35];
P = .91).
Study-specific ambulance data collection forms record-
ing delivery of the PASTA pathway were located for 227 of 500
patients (45.5%) in the intervention group. Use of the struc-
tured handover was recorded for 134 of 227 patients (59.0%).
Full data are shown in eTable 6 in Supplement 1.
Discussion
This multisite pragmatic trial showed that a paramedic-led
thrombolysis-focused emergency stroke assessment that ex-
tended beyond hospital handover did not increase thromboly-
sis rates. Instead, a nonsignificant reduction in thrombolysis
administration was observed. Although there was a longer ini-
tial paramedic assessment process, it is unlikely that the PASTA
intervention resulted in patients simply timing out of treat-
ment, because this was proportionally a minor extension of
the whole emergency pathway, and the Cox regression analy-
sis indicated that intervention thrombolysis was less likely at
any point since the emergency call.
It may be surprising that the PASTA pathway did not im-
prove thrombolysis delivery when simpler prehospital inter-
ventions have increased treatment rates (eg, raising the am-
bulance priority level for suspected stroke7) and reduced
hospital treatment delays (eg, prenotification8), but the ser-
vice context of each report is likely to be relevant. Previously,
additional thrombolysis activity was observed at 4 of 6 US
centers following a multilevel intervention including public
Figure 2. Trial Diagram
1540 Paramedics in 121 ambulance
stations randomized
156 Paramedics were unable or refused
to participate
208 Paramedics did not complete the 
required PASTA training
453 Paramedics participated in the study
348 Patients with day 90 follow-up data expected
305 Patients with day 90 follow-up data available
43 Patients with day 90 follow-up data not available
1.8 Patients with day 90 data per attending paramedic
(305 patients and 168 paramedics)
1 Patient withdrawn
140 Patients died
11 Patients not expected to have 90-d
assessment for reasons other than death
500 Patients consented
242 Paramedics involved
2.1 Patients consenting per
attending paramedic
500 Patients with primary outcome
data available
2.1 Patients with primary outcome
data per attending paramedic
23 Paramedics were unable or refused
to participate
700 Paramedics participated in the study
453 Patients with day 90 follow-up data expected
374 Patients with day 90 follow-up data available
79 Patients with day 90 follow-up data not available
1.6 Patients with day 90 data per attending paramedic
(374 patients and 231 paramedics)
4 Patients withdrawn
199 Patients died
58 Patients not expected to have 90-d
assessment for reasons other than death
714 Patients consented
355 Paramedics involved
2.0 Patients consenting per
attending paramedic
714 Patients with primary outcome
data available
2.0 Patients with primary outcome
data per attending paramedic
817 Paramedics in 62 ambulance stations
randomized to PASTA pathway
723 Paramedics in 59 ambulance stations
randomized to usual stroke care
Seven hundred paramedics
participated in the study while
continuing standard care, of whom 8
completed PASTA training during the
course of the study. PASTA indicates
Paramedic Acute Stroke Treatment
Assessment.
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awareness activities, a paramedic symptom checklist, and com-
petitive benchmarking.6 The 2 unchanged centers had high
baseline treatment rates and may have already achieved op-
timal performance. A similar ceiling effect may explain the lack
of effect among PASTA sites, which were already established
thrombolysis providers. A multisite Scandinavian trial7 ran-
domized 942 patients with suspected stroke or transient is-
chemic attack to a higher vs a standard response level after mul-
tidisciplinary training and reported a thrombolysis rate of 24%
compared with 10% among the control group. As with PASTA,
there was no significant change in door-to-needle time,
suggesting that delays following admission are more likely to
reflect logistical factors, such as scan capacity, image report-
ing, and specialist availability. In our results, the relatively long
mean door-to-needle time in standard care of 54 minutes may
indicate services that lacked the logistical capacity to im-
prove. It is important to recognize that PASTA did not change
public awareness, priority response level, identification, or
prenotification. Because UK standard care already includes
these components, incremental gains from new interven-
tions become harder to achieve, and an enhanced para-
medic assessment may not be powerful enough to augment
treatment delivery in contemporary thrombolysis-active
services.
Despite the intervention group showing a surprising non-
significant finding of fewer thrombolysis treatments, out-
comes were not adversely affected and there was a counter-
intuitive nonsignificant result of better health at day 90. It is
important to acknowledge that statistical power for any sec-
ondary outcome was lacking, and such differences between
groups may simply reflect chance. However, if indicative of a
genuine effect, one possible hypothesis for this apparent para-
dox is an influence on case selection; ie, structured commu-
nication of directly relevant and timely information by PASTA
paramedics might increase clinician confidence about with-
holding treatment when there is borderline benefit, higher-
than-typical risk, or uncertainty about key details, such as
onset time. The post hoc analysis showed that intervention-
group thrombolysis was significantly less likely across ser-
vices with specialist availability below the level recom-
mended by national guidelines. Relatively inexperienced
clinicians under time pressure may tend toward overtreat-
ment rather than undertreatment of patients with borderline
cases, which could be moderated by the PASTA handover
and/or checklist, whereas services with greater specialist con-
tinuity may already apply a more systematic approach to case
selection. Because this was an unexpected finding, we had not
collected the required data describing clinical and radiologi-
cal quality of individual treatment decisions to confirm this
hypothesis, and therefore further research is needed. How-
ever, previous emergency department studies have reported
that typically, less than half of pertinent data points are shared
during standard handover of mixed patient groups,22 with sig-
nificant variation attributable to clinician experience.11,23 The
relevance and clarity of handover can be improved by intro-
duction of simple generic formats,10,24 while multidisci-
plinary team checklists make care safer through clarification
of information and reinforcement of important standards.12,13
Limitations
A key limitation of the study was the inability to mask group
allocation from clinicians because of the nature of the inter-
vention, but the lack of imbalance in baseline characteristics
Table 1. Demography and Clinical Characteristics
Characteristic PASTA Standard care
Total 500 714
Sex, No. (%)
Male 259 (51.8) 365 (51.1)
Female 241 (48.2) 349 (48.9)
Age, median (interquartile range), y 76.5 (68.0-84.0) 77.0 (67.8-84.0)
Prestroke modified Rankin scale
score, No. (%)
Patients with data available 494 (100) 708 (100)
0 233 (47.2) 341 (48.2)
1 78 (15.8) 126 (17.8)
2 65 (13.2) 79 (11.2)
3 66 (13.4) 97 (13.7)
4 42 (8.5) 47 (6.6)
5 10 (2.0) 18 (2.5)
0-2 376 (76.1) 546 (77.1)
3-5 118 (23.9) 162 (22.9)
Stroke severity at admission, NIHSS
score
Patients with data available 499 (100) 710 (100)
Median (interquartile range) 8 (4-17) 9 (4-19)
Mean (SD) 11.1 (8.7) 11.5 (8.5)
Results of the first brain imaging,
No. (%)
Patients with data available 499 (100) 714 (100)
Infarction 409 (82.0) 607 (85.0)
Primary intracerebral hemorrhage 90 (18.0) 106 (14.8)
Other 0 1 (0.1)
Blood pressure on admission
Systolic
Patients with data available, No. 497 712
Median (interquartile range) 158 (136-178) 158 (138-175)
Mean (SD) 158.4 (30.8) 157.4 (29.8)
Diastolic
Patients with data available, No. 497 712
Median (interquartile range) 85 (73-97) 82 (71-94)
Mean (SD) 85.2 (19.0) 83.9 (18.2)
Blood glucose on admission
Patients with data available, No. 478 682
Median (interquartile range) 6.7 (5.7-7.9) 6.7 (5.7-8.1)
Mean (SD) 7.4 (2.8) 7.4 (3.2)
Anticoagulation on admission,
No. (%)
Patients with data available 499 (100) 713 (100)
Warfarin 42 (8.4) 51 (7.2)
Apixaban 9 (1.8) 24 (3.4)
Rivaroxaban 12 (2.4) 22 (3.1)
Dabigatran 3 (0.6) 2 (0.3)
Abbreviation: PASTA, Paramedic Acute Stroke Treatment Assessment.
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makes selection bias an unlikely explanation for the results.
Better health outcomes might also result if the interven-
tion favored labelling less disabling mimic conditions as
stroke, but this seems unlikely, because patients were only
enrolled after local specialist confirmation of a stroke diag-
nosis. Challenging operational conditions impeded objec-
tive confirmation of intervention fidelity, and approxi-
mately half of the study ambulance data forms were not
returned, despite efforts to encourage completion. How-
ever, since the mean additional time spent by PASTA para-
medics on each call was nearly 15 minutes, and all had com-
pleted the study training, it is probable that some aspects of
the intervention were being performed. As a pragmatic real-
world evaluation across multiple sites with an inclusive
consent strategy, the result remains relevant for modern
clinical services.
Table 2. Thrombolysis Treatment
Outcome
Patients in
PASTA group,
No. (%)
Patients in SC
group, No. (%)
Odds ratios (95% CI) or
difference in mean
PASTA − standard care
outcomes (95% CI) P value
Thrombolysis treatment
All patients
Unadjusted odds ratio (95% CI)
197a (39.4) 319a (44.7)
0.81 (0.64-1.02) .07
Adjusted odds ratio (95% CI) 0.81 (0.61-1.08) .15
Ischemic stroke only
Unadjusted odds ratio (95% CI)
196b,c (47.9) 319b (52.6)
0.83 (0.65-1.07) .15
Adjusted odds ratio (95% CI) 0.84 (0.60-1.17) .30
8 AM to 8 PM
Unadjusted odds ratio (95% CI)
130d (39.0) 208d (45.2)
0.78 (0.58-1.03) .08
Adjusted odds ratio (95% CI) 0.80 (0.55-1.15) .23
8 PM to 8 AM
Unadjusted odds ratio (95% CI)
46e (38.0) 79e (41.4)
0.87 (0.55-1.39) .56
Adjusted odds ratio (95% CI) 0.85 (0.46-1.56) .59
Complications after thrombolysis,
No. (%)
Patients, No. 196 316 NA NA
Symptomatic intracranial
hemorrhage
4 (2.0) 10 (3.1) 0.64 (0.20-2.10) .46
Extracranial hemorrhage 6 (3.1) 6 (1.9) 1.65 (0.52-5.20) .39
Angioedema 2 (1.0) 7 (2.2) 0.46 (0.10-2.24) .32
Other complication 2 (1.0) 1 (0.3) 3.3 (0.30-36.40) .56
Any complication 13 (6.6) 24 (7.5) 0.87 (0.43-1.76) .70
Stroke onset to thrombolysis treatment
time, min
Patients, No. 197 319 NA NA
Mean (SD) 154.4 (55.3) 149.9 (51.7) 4.47 (−4.97 to 13.93)f .35
Median (interquartile range) 146 (110-194) 137 (110-190) NA NA
Paramedic assessment to thrombolysis
treatment time, min
Patients, No. 194 315 NA NA
Mean (SD) 98.1 (37.6) 89.6 (31.1) 8.50 (2.10-14.80)f .01
Median (interquartile range) 90 (72-114) 86 (68-107) NA NA
Hospital arrival to thrombolysis
treatment time, min
Patients, No. 176 286 NA NA
Mean (SD) 58.9 (33.4) 54.2 (26.9) 4.69 (−1.20 to 10.55)f .12
Median (interquartile range) 48.5 (35-75) 48.5 (36-65) NA NA
Stroke severityg
After thrombolysis treatment
(24-48 h)
Patients, No. 193 307 NA NA
Mean (SD) 8.5 (9.0) 9.6 (9.3) −1.12 (−2.7 to 0.54)f .19
Median (interquartile range) 5 (1-14) 6 (2-15) NA NA
Reduction after thrombolysis
treatment
Patients, No. 193 307 NA NA
Mean (SD) 3.7 (6.5) 2.8 (7.2) 0.90 (−0.35 to 2.2)f .16
Median (interquartile range) 4 (0-7) 3 (0-7) NA NA
Abbreviations: OR, odds ratio;
PASTA, Paramedic Acute Stroke
Treatment Assessment; SC, standard
care group.
a PASTA group, n = 500; SC group,
n = 714.
b PASTA group, n = 409; SC group,
n = 607.
c This is 196 patients, not 197,
because 1 patient with a subtle
hemorrhagic stroke who was not
initially identified on the admission
computed tomography scan
received thrombolysis.
d PASTA group, n = 333; SC group,
n = 460.
e PASTA group, n = 121; SC group,
n = 191.
f Difference in mean PASTA and
standard care outcome.
g National Institutes of Health Stroke
Scale score.
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Conclusions
The PASTA trial showed that incremental improvements in
thrombolysis delivery are unlikely to be achieved through
isolated use of more sophisticated prehospital assessments.
An unexpected finding led us to consider whether structured
handover of additional information and/or a multidisci-
plinary checklist could improve the selection of patients for
thrombolysis, particularly in hospitals with lower levels of
specialist availability. Further research is required to confirm
this hypothesis and demonstrate whether the intervention
promotes quality rather than quantity during emergency
stroke care.
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